NHHR and Cardiovascular Outcomes in Diabetic Patients Post-PCI, 2019-2023

A retrospective cohort study of 1,176 adults with type 2 diabetes undergoing percutaneous coronary intervention after acute myocardial infarction, conducted between January 1, 2019, and December 31, 2023. The data, authored by Xi He and shared on figshare, investigates the association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and major adverse cardiovascular events over a follow-up period averaging 21.0 ± 6.6 months.

Use Cases

• Predicting major adverse cardiovascular event risk based on the NHHR lipid ratio.
• Analyzing the non-linear relationship between NHHR and post-PCI outcomes using restricted cubic splines.
• Evaluating the prognostic significance of NHHR combined with the Global Registry of Acute Coronary Events risk score.
• Conducting subgroup analyses for age, sex, hypertension, smoking, and other clinical variables.

Strengths

• Dataset includes 1,176 patient records with a defined follow-up period of 21.0 ± 6.6 months.
• Multivariate analysis results, including hazard ratios and confidence intervals, are provided in the description.
• The study defines a specific threshold range (3.12–5.10) for the NHHR metric where risk increases.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small at 15.0 KB, suggesting limited scope or summary-level data.

Provenance

Source

figshare

Collection Method

Retrospective cohort study of patients from a single institution.

Time Range

2019-01-01 to 2023-12-31

Freshness

Last updated 2026-05-15 04:26:27; freshness should be verified.